A Novel Diagnostic Biomarker, PZP, for Detecting Colorectal Cancer in Type 2 Diabetes Mellitus Patients Identified by Serum-Based Mass Spectrometry
Background: Growing evidence has confirmed that populations with type 2 diabetes mellitus (T2DM) have an increasing risk of developing colorectal cancer (CRC). Thus, convenient and effective screening strategies for CRC should be developed for the T2DM population to increase the detection rate of CR...
Guardado en:
Autores principales: | Jiayue Yang, Weigang Fang, Wenjun Wu, Zhen Tian, Rong Gao, Lu Yu, Dayang Chen, Xiaohua Weng, Shengwei Zhu, Cheng Yang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7b7d3051e1494d88a55880349c2c8e84 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
International journal of mass spectrometry
Publicado: (1998) -
Serum Untargeted UHPLC-HRMS-Based Lipidomics to Discover the Potential Biomarker of Colorectal Advanced Adenoma
por: Zhu Y, et al.
Publicado: (2021) -
Faecal Diagnostic Biomarkers for Colorectal Cancer
por: Andrea Cruz, et al.
Publicado: (2021) -
Proinflammatory cytokines and colorectal cancer – the impact of the stage
por: Lyudmila Akhmaltdinova, et al.
Publicado: (2021) -
Novel Methylation Biomarkers for Colorectal Cancer Prognosis
por: Alvaro Gutierrez, et al.
Publicado: (2021)